Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Embolic protection device enters US trial:

This article was originally published in Clinica

Executive Summary

A multicentre clinical trial of Embolic Protection's filter for removing particles and blood clots during angioplasty and vascular interventions is underway in the US. The FilterWire EX is initially being assessed in 30 saphenous vein graft interventions, but a larger safety and efficacy trial is planned for early next year, says the Campbell, California company. The filter is attached to a 0.014 inch guidewire and can be inserted into a vessel through a 3F catheter. It allows blood to flow continuously through a vessel and can pass through much smaller arteries compared with other embolic protection devices, Milt McColl, Embolic's chief medical officer told Clinica.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075385

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel